Contact usMarket Leader in providing High throughput Direct RT-PCR COVID-19 Diagnostics
ORDER HEREOur R2 combo Workflow
ORDER HEREEasy Implementation
Wide Applicability
RESOLUTE received Provisional Authorization from Health Sciences Authority (HSA) Singapore in May 2020.
In collaboration with
Key Specifications
Our RAVE programs
Our packages
Market Leader in providing High throughput Direct RT-PCR COVID-19 Diagnostics
Our R2 combo Workflow
We meet your COVID-19 diagnostic needs
Speed
Sensitivity
Easy Implementation
Wide Applicability
Abolish RNA extraction step
Full automation
5760 samples per day
Limit of Detection of 50 copies per reaction
Open system to enable flexibility in the use of standard laboratory equipment including qPCR machines and UTM sample tubes
Point-of-care Testing: Clinics and Emergency Rooms
HIgh throughput Facilities: Central Labs and Screening Centers
We combine our RNA-extraction free COVID-19 diagnostic kit (RESOLUTE) and high throughput automation platform (RAVE) into a integrative open platform.
We close the market gap and outshine our competitors by covering your end-to-end needs for COVID-19 testing.
© 2020 Advanced MedTech. All Rights Reserved.
Order information and product support:
AMT Pte Ltd
3 Tuas Lane Singapore 638612
prdt-resolute@amt-mat.com
RESOLUTE received Provisional Authorization from Health Sciences Authority (HSA) Singapore in May 2020.
In collaboration with
Key Specifications
Our RAVE programs
ORDER HERE
